Darmstadt, Germany

Patrick Keller

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Patrick Keller

Introduction

Patrick Keller, an accomplished inventor based in Darmstadt, Germany, has made significant strides in the field of biotechnology. With a total of 11 patents to his name, Keller focuses primarily on the development of antibodies that target amyloid beta protein, a key factor in neurodegenerative disorders such as Alzheimer's disease.

Latest Patents

Keller's recent patents include groundbreaking work on "Anti-Aβ globulomer 4D10 antibodies," which detail various aspects such as antigen-binding moieties, hybridomas, and therapeutic methods for producing these antibodies. His invention particularly emphasizes anti-Aβ globulomer antibodies, which possess a higher binding affinity to Aβ(20-42) globulomer compared to Aβ(1-42) globulomer. This advancement holds promise for diagnostic and therapeutic applications in treating Alzheimer’s disease and other amyloidoses. Another of his notable patents focuses on monoclonal antibodies against amyloid beta protein, specifically antibodies 8F5 and 8C5, which are intended for use in prevention, treatment, and diagnosis of Alzheimer's disease or other neurodegenerative disorders.

Career Highlights

Patrick Keller's career has been marked by his associations with prominent companies such as AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His work in these organizations demonstrates his commitment to advancing medical science and his expertise in antibody development.

Collaborations

Throughout his career, Keller has collaborated with notable professionals in the field, including colleagues Stefan Barghorn and Heinz Hillen. These collaborations have allowed him to further refine his research and contribute more significantly to the scientific community.

Conclusion

Patrick Keller's contributions to biotechnology, particularly in the area of Alzheimer’s disease research, underscore the importance of innovation in addressing complex medical challenges. His extensive patent portfolio reflects his dedication and ingenuity as an inventor, making him a key figure in the ongoing battle against neurodegenerative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…